A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
Clinical trial NCT02608684 · COMPLETED
Trial details
- NCT number
- NCT02608684
- Sponsor
- Cedars-Sinai Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-08
- Primary completion
- 2019-05-17
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.